China, Aug. 25 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'An open, multicenter Phase I clinical study on the safety, efficacy and pharmacokinetics of SH006 injection in patients with advanced solid tumors'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600130704

Registration Time: 2026/08/24

Type: Interventional study

Primary Sponsor: Nanjing Tianyi Mountain Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=285763

Published by HT Digital Content Services with permission from Health Daily Digest....